Genmab shares fall 3% after Q3 revenue slightly misses expectations
Summary
Genmab experienced a three percent drop in its share price following its latest financial results. The decline occurred after the company reported third-quarter revenue that came in slightly below market expectations.
Source: Read the full story at Stock Market News
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.